New Key Statistics Module, Z-Score and F-Score
NAS:FATE Key Ratios
Market Cap $ M | 472.41 |
Enterprise Value $ M | 201.18 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.13 |
Price/Sales | 65.23 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 6.00 |
EPS (TTM) $ | -1.92 |
Beneish M-Score | -6.66 |
10-y EBITDA Growth Rate % | -3.70 |
5-y EBITDA Growth Rate % | -15.10 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.94 |
EV-to-EBITDA | -1.04 |
PEG | -- |
Shares Outstanding M | 113.83 |
Net Margin (%) | -2,933.79 |
Operating Margin % | -3,287.85 |
Pre-tax Margin (%) | -2,933.79 |
Quick Ratio | 8.69 |
Current Ratio | 8.69 |
ROA % (ttm) | -33.52 |
ROE % (ttm) | -44.98 |
ROIC % (ttm) | -112.06 |
Dividend Yield % | -- |
Altman Z-Score | -1.43 |
FATE Number of Guru Trades
FATE Volume of Guru Trades
Gurus Latest Trades with NAS:FATE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:FATE is held by these investors
Total 1
Fate Therapeutics Inc Insider Transactions
No Available Data
News about NAS:FATE
Total 0- 1